Initiate and Maintain Physical Activity in Clinics: The IMPACT Diabetes Study (IMPACT)
15. marts 2021 opdateret af: Latha Palaniappan, MD, MS, Stanford University
The Initiate and Maintain Physical Activity in Clinics (IMPACT) study will determine the optimal and feasible level of frequency of structured contact needed in a clinical setting for adult patients with Type 2 Diabetes Mellitus to initiate and maintain physical activity recommendations long-term.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The IMPACT Study will compare the health outcomes and lifestyle habits amongst the three groups of study participants.
Study participants will be randomized into three exercise group.
Group 1 will participate in instructor-led exercise training sessions 1 time per week, for 24 weeks (approximately 6 months).
Group 2 will participate in instructor-led exercise training sessions 3 times per week, for 24 weeks (approximately 6 months).
Group 3 will not attend any instructor-led exercise training sessions.
All groups will be encouraged to see their usual providers for routine healthcare, and continue their usual medication regimen.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
354
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
Palo Alto, California, Forenede Stater, 94304
- Stanford University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 80 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Recent hemoglobin A1c result between 6.5 and 13.0%
- Diagnosed with Type 2 Diabetes Mellitus
- Able and willing to enroll and meet the requirements of the study
Exclusion Criteria:
- Inability to speak, read or understand English
- Long-term current use or dependency on insulin
- Systolic blood pressure >180 mm Hg or diastolic blood pressure >100 mm Hg
- Resting heart rate > 120 bpm
- History of or present heart or cardiovascular conditions
- History of or present respiratory disease
- History of or present spinal cord injury
- History of stroke or Transient Ischemic Attack (TIA)
- History of cancer diagnosis in the past 5 years or present cancer diagnosis
- Medical, psychiatric, behavioral limitations that may interfere with study participation
- Participating in other clinical trials that may interfere with study procedures and outcomes
- Currently pregnant or plans to become pregnant within three years
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Once-Weekly Structured Contact
Participants in the Once Weekly Structured Contact group will take part in an 6-month exercise intervention and attend one structured group exercise session per week.
They will engage in aerobic and resistance training for approximately 80 minutes per exercise session.
Additionally, they will attend three exercise evaluations and six study visits.
|
The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting.
Group sessions include Aerobic Training and Combined Training.
Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week.
Participants in both groups will attend three exercise evaluations during the intervention period.
Participants will also use provided logs to track their daily exercise activities outside of group sessions.
Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.
|
|
Eksperimentel: Thrice-Weekly Structured Contact
Participants in the Thrice-Weekly Structured Contact group will take part in an 6-month exercise intervention and attend three structured group exercise sessions per week.
In total, they will engage in aerobic and resistance training sessions for approximately 200 minutes per week.
Additionally, they will attend three exercise evaluations and six study visits.
|
The study intervention is a 6-month exercise program with structured group sessions conducted in a clinical setting.
Group sessions include Aerobic Training and Combined Training.
Once-Weekly participants will attend one Combined Training session while thrice-weekly participants will attend two Combined Training sessions and one Aerobic Training session per week.
Participants in both groups will attend three exercise evaluations during the intervention period.
Participants will also use provided logs to track their daily exercise activities outside of group sessions.
Physical activity will be assessed by group session attendance, exercise resistance and intensity, and exercise frequency data collected from exercise logs, surveys, and evaluations.
|
|
Ingen indgriben: Usual Care
Participants in the Usual Care group will not take part in an 6-month exercise intervention.
They will continue to seek regular care from their primary care providers and attend six study visits.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Changes in Hemoglobin A1c Level Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Maximal Oxygen Consumption Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Self-Reported Physical Activity Level Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Changes in Body Weight Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Body Mass Index Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Waist Circumference Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Blood Pressure Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Heart Rate Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Dietary Intake Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Self-Reported Quality of Life Across Study Visits
Tidsramme: Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
Baseline, 3-, 6-, 18-, 24-, 30-month follow-up
|
|
Changes in Exercise Perception Across Study Visits
Tidsramme: Baseline, 6-, 30-month follow-up
|
Baseline, 6-, 30-month follow-up
|
|
Changes in Patient Satisfaction During Intervention Period
Tidsramme: 3-, 6-month follow-up
|
3-, 6-month follow-up
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
1. oktober 2016
Primær færdiggørelse (Faktiske)
1. januar 2020
Studieafslutning (Faktiske)
1. januar 2020
Datoer for studieregistrering
Først indsendt
11. februar 2014
Først indsendt, der opfyldte QC-kriterier
11. februar 2014
Først opslået (Skøn)
13. februar 2014
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
17. marts 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
15. marts 2021
Sidst verificeret
1. marts 2021
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 31635
- U.S. NIH Grant 5R18DK096394 (Andet bevillings-/finansieringsnummer: U.S. NIH Grant/Contract Award Number)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .